ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO422

Neonatal Kidney Stem/Progenitor Cells (nKSPCs) Downregulate Activation of Human Neutrophils In Vitro

Session Information

Category: Development, Stem Cells, and Regenerative Medicine

  • 600 Development, Stem Cells, and Regenerative Medicine

Authors

  • Chen, Junyu, Amsterdam UMC Locatie AMC, Amsterdam, Noord-Holland, Netherlands
  • Gouwy, Mieke, Katholieke Universiteit Leuven, Leuven, Flanders, Belgium
  • Proost, Paul, Katholieke Universiteit Leuven, Leuven, Flanders, Belgium
  • Akalay, Sara, Katholieke Universiteit Leuven, Leuven, Flanders, Belgium
  • Lantermans, Hildo C., Amsterdam UMC Locatie AMC, Amsterdam, Noord-Holland, Netherlands
  • Van den Heuvel, Lambertus P.W.J., Radboud Universiteit, Nijmegen, Gelderland, Netherlands
  • Arcolino, Fanny Oliveira, Amsterdam UMC Locatie AMC, Amsterdam, Noord-Holland, Netherlands
  • Levtchenko, Elena, Amsterdam UMC Locatie AMC, Amsterdam, Noord-Holland, Netherlands

Group or Team Name

  • Translational Paediatric Nephrology.
Background

Neonatal Kidney Stem/Progenitor Cells (nKSPC), a novel type of kidney progenitor cell, isolated from urine of preterm neonates, have demonstrated immunoregulatory capacity and can inhibit proliferation of T-lymphocytes in mixed lymphocyte reaction. Our group is testing nKSPC as a potential source of cell therapy in the context of kidney transplantation. Neutrophils play important roles in ischemia-reperfusion injury (IRI), a common occurrence in kidney transplantation. In this study, we examined the capacity of nKSPC to inhibit human neutrophils in vitro.

Methods

Freshly isolated neutrophils activated by TNF-α were co-cultured with nKSPC at varying ratios (10:1 to 500:1). CD16 and CD66b as markers related to neutrophil activation were measured by Fluorescence-Activated Cell Sorting (FACS). Apoptosis was analyzed by Annexin V assay in FACS. Assessing neutrophil-produced reactive oxygen species (ROS), we employed a Luminol assay under multiple stimuli (TNF-α, IL-1β, fMLF, PGN). Neutrophil chemotaxis was investigated by Boyden chamber assay.

Results

Neutrophils, stimulated by TNF-α, exhibit increased CD66b and decreased CD16 expression, indicating activation. TNF-α also induced apoptosis of neutrophils. Co-culturing with nKSPC significantly reduced TNF-α-induced neutrophil activation and apoptosis. TNF-α, IL-1β, fMLF, and PGN stimulation promoted ROS production in neutrophils, and a co-culture with nKSPC inhibited this induction. Neutrophil chemotaxis induced by TNF-α was not inhibited by nKSPC.

Conclusion

Our in vitro data show the immunomodulatory capacity of nKSPC on neutrophils with decreased activation, reduction of apoptosis and abolishing ROS production.

Funding

  • Government Support – Non-U.S.